Literature DB >> 16177318

Minimum infective dose of Mycobacterium bovis in cattle.

Gillian S Dean1, Shelley G Rhodes, Michael Coad, Adam O Whelan, Paul J Cockle, Derek J Clifford, R Glyn Hewinson, H Martin Vordermeier.   

Abstract

The aim of this work was to determine the minimum infective dose of Mycobacterium bovis necessary to stimulate specific immune responses and generate pathology in cattle. Four groups of calves (20 animals) were infected by the intratracheal route with 1,000, 100, 10, or 1 CFU of M. bovis. Specific immune responses (gamma interferon [IFN-gamma] and interleukin-4 [IL-4] responses) to mycobacterial antigens were monitored throughout the study, and the responses to the tuberculin skin test were assessed at two times. Rigorous post mortem examinations were performed to determine the presence of pathology, and samples were taken for microbiological and histopathological confirmation of M. bovis infection. One-half of the animals infected with 1 CFU of M. bovis developed pulmonary pathology typical of bovine tuberculosis. No differences in the severity of pathology were observed for the different M. bovis doses. All animals that developed pathology were skin test positive and produced specific IFN-gamma and IL-4 responses. No differences in the sizes of the skin test reactions, the times taken to achieve a positive IFN-gamma result, or the levels of the IFN-gamma and IL-4 responses were observed for the different M. bovis doses, suggesting that diagnostic assays (tuberculin skin test and IFN-gamma test) can detect cattle soon after M. bovis infection regardless of the dose. This information should be useful in modeling the dynamics of bovine tuberculosis in cattle and in assessing the risk of transmission.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177318      PMCID: PMC1230957          DOI: 10.1128/IAI.73.10.6467-6471.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle.

Authors:  H M Vordermeier; A Whelan; P J Cockle; L Farrant; N Palmer; R G Hewinson
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  The role of particle size in experimental air-borne infection.

Authors:  L S SONKIN
Journal:  Am J Hyg       Date:  1951-05

3.  Pathogenesis and diagnosis of infections with Mycobacterium bovis in cattle. Independent Scientific Group on Cattle TB.

Authors:  W I Morrison; F J Bourne; D R Cox; C A Donnelly; G Gettinby; J P McInerney; R Woodroffe
Journal:  Vet Rec       Date:  2000-02-26       Impact factor: 2.695

4.  Shedding of Mycobacterium bovis in the nasal mucus of cattle infected experimentally with tuberculosis by the intranasal and intratracheal routes.

Authors:  T McCorry; A O Whelan; M D Welsh; J McNair; E Walton; D G Bryson; R G Hewinson; H M Vordermeier; J M Pollock
Journal:  Vet Rec       Date:  2005-11-12       Impact factor: 2.695

5.  Differential cytokine responses of CD4+ and CD8+ T cells in response to bovine viral diarrhoea virus in cattle.

Authors:  S G Rhodes; J M Cocksedge; R A Collins; W I Morrison
Journal:  J Gen Virol       Date:  1999-07       Impact factor: 3.891

6.  Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis.

Authors:  H Martin Vordermeier; Mark A Chambers; Paul J Cockle; Adam O Whelan; Jennifer Simmons; R Glyn Hewinson
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 7.  IL-4 in tuberculosis: implications for vaccine design.

Authors:  Graham A W Rook; Rogelio Hernandez-Pando; Keertan Dheda; Geok Teng Seah
Journal:  Trends Immunol       Date:  2004-09       Impact factor: 16.687

8.  Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis.

Authors:  Konstantin Lyashchenko; Adam O Whelan; Rena Greenwald; John M Pollock; Peter Andersen; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

9.  An analysis of cellular proliferation, and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle.

Authors:  D L Emery; J H Dufty; P R Wood
Journal:  Vet Immunol Immunopathol       Date:  1988-02       Impact factor: 2.046

10.  Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2.

Authors:  Abebech Demissie; Markos Abebe; Abraham Aseffa; Graham Rook; Helen Fletcher; Alimuddin Zumla; Karin Weldingh; Inger Brock; Peter Andersen; T Mark Doherty
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

View more
  32 in total

1.  Field evaluation of a novel differential diagnostic reagent for detection of Mycobacterium bovis in cattle.

Authors:  P J Cockle; S V Gordon; R G Hewinson; H M Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

2.  Experimental model of tuberculosis in the domestic goat after endobronchial infection with Mycobacterium caprae.

Authors:  Bernat de Val Pérez; Sergio López-Soria; Miquel Nofrarías; Maite Martín; H Martin Vordermeier; Bernardo Villarreal-Ramos; Nadine Romera; Manel Escobar; David Solanes; Pere-Joan Cardona; Mariano Domingo
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

Review 3.  Ecology and evolution of Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux
Journal:  Nat Rev Microbiol       Date:  2018-02-19       Impact factor: 60.633

4.  Ultra-low dose of Mycobacterium tuberculosis aerosol creates partial infection in mice.

Authors:  Divey Saini; Gregory W Hopkins; Sarah A Seay; Ching-Ju Chen; Casey C Perley; Eva M Click; Richard Frothingham
Journal:  Tuberculosis (Edinb)       Date:  2011-12-21       Impact factor: 3.131

5.  Is interleukin-4delta3 splice variant expression in bovine tuberculosis a marker of protective immunity?

Authors:  Shelley G Rhodes; Jason Sawyer; Adam O Whelan; Gillian S Dean; Michael Coad; Katie J Ewer; Andreas S Waldvogel; Anthony Zakher; Derek J Clifford; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2007-03-26       Impact factor: 3.441

6.  Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.

Authors:  A S Mustafa; Y A Skeiky; R Al-Attiyah; M R Alderson; R G Hewinson; H M Vordermeier
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

7.  Screening of predicted secreted antigens from Mycobacterium bovis identifies potential novel differential diagnostic reagents.

Authors:  Gareth J Jones; R Glyn Hewinson; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2010-07-28

8.  Screening of predicted secreted antigens from Mycobacterium bovis reveals the immunodominance of the ESAT-6 protein family.

Authors:  Gareth J Jones; Stephen V Gordon; R Glyn Hewinson; H Martin Vordermeier
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

9.  Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.

Authors:  H Martin Vordermeier; Bernardo Villarreal-Ramos; Paul J Cockle; Martin McAulay; Shelley G Rhodes; Tyler Thacker; Sarah C Gilbert; Helen McShane; Adrian V S Hill; Zhou Xing; R Glyn Hewinson
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

10.  The prevalence, distribution and severity of detectable pathological lesions in badgers naturally infected with Mycobacterium bovis.

Authors:  H E Jenkins; W I Morrison; D R Cox; C A Donnelly; W T Johnston; F J Bourne; R S Clifton-Hadley; G Gettinby; J P McInerney; G H Watkins; R Woodroffe
Journal:  Epidemiol Infect       Date:  2007-11-30       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.